FDA & Government News

June 29, 2026

FDA Approves New Treatment for Thyroid Eye Disease

Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.

Conexiant

May 29, 2026

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

April 29, 2026

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

April 20, 2026

Dual-Agent Eye Drop for Presbyopia

YUVEZZI™ approved for the treatment of presbyopia, blurry close-up vision due to aging

The Ophthalmologist

March 26, 2026

St. Louis Pediatrician Gets 20-Year Sentence

A physician exploited patients with addiction for nearly a decade, trading prescriptions for sex acts, photos, and cash

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

March 23, 2026

FDA Approves TECNIS PureSee IOL for Cataract Surgery

First FDA-approved extended depth of focus (EDOF) IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL

The Ophthalmologist

March 12, 2026

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

Conexiant

February 25, 2026

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.

Conexiant

January 14, 2026

FDA Clears Rayner's Sophi Phaco System

The company said that surgeons and clinical teams can benefit from faster setup, quicker patient turnover, and greater mobility.

Ophthalmology Management

January 06, 2026

Privosegtor Receives Breakthrough Drug Designation

In a phase 2 trial, the drug showed functional and structural signals in optic neuritis.

Retinal Physician

Benchmark for Functional Vision Loss Uncovered in Older Adults

FDA & Government News

FDA Approves New Treatment for Thyroid Eye Disease

FDA Monthly Preview: Key June Decisions to Watch

FDA Monthly Preview: Key May Decisions to Watch

Dual-Agent Eye Drop for Presbyopia

St. Louis Pediatrician Gets 20-Year Sentence

Daily News

FDA Approves TECNIS PureSee IOL for Cataract Surgery

Cataract Surgeons Gain a New Lens Tool

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

FDA Clears Rayner's Sophi Phaco System

Privosegtor Receives Breakthrough Drug Designation

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

Benchmark for Functional Vision Loss Uncovered in Older Adults

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

Conexiant

AACE Endocrinology AI

Conexiant

GI & Hepatology News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

FDA & Government News

Daily News

Recommendations